Ziming Wang
Luoyang, 471003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
MetaboHealth and Metabolic Vulnerability Index as Risk Factors for Cardio-Renal-Metabolic Multimorbidity: A Large-Scale Prospective Cohort Study.
Journal: Diabetes, obesity & metabolism
Published: May 29, 2026
Super-enhancer-driven KIAA1522 upregulation suppresses ferroptosis in hepatocellular carcinoma.
Journal: Clinical and translational medicine
Published: January 26, 2026
Extracellular vesicles as a novel mediator of interkingdom communication.
Journal: Cytokine & growth factor reviews
Published: July 28, 2023
The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer.
Journal: Annals of translational medicine
Published: October 18, 2022
Chidamide Reverses Fluzoparib Resistance in Triple-Negative Breast Cancer Cells.
Journal: Frontiers in oncology
Published: November 22, 2021
The Synergistic Effects of SHR6390 Combined With Pyrotinib on HER2+/HR+ Breast Cancer.
Journal: Frontiers in cell and developmental biology
Published: September 29, 2021
MiR-16-5p suppresses breast cancer proliferation by targeting ANLN.
Journal: BMC cancer
Published: May 16, 2021
Bioinformatics analysis on enrichment analysis of potential hub genes in breast cancer.
Journal: Translational cancer research
Published: March 09, 2021
Overexpression of SEZ6L2 predicts poor prognosis in patients with cholangiocarcinoma.
Journal: Translational cancer research
Published: March 16, 2020
Nudix hydrolase 1 is a prognostic biomarker in hepatocellular carcinoma.
Journal: Aging
Published: October 09, 2019
Last Updated: 09/26/2026